Lorianne Masuoka
CMO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | DiaMedica Therapeutics Inc. (DMAC) | Chief Medical Officer | $403,277 | $1,174,310 |
Executive changes
Earnings-call appearances
-
DiaMedica Therapeutics Inc. Q4 FY2024 Earnings Call2025-03-17
DiaMedica Therapeutics Inc. (DMAC)
-
DiaMedica Therapeutics Inc. Q3 FY2024 Earnings Call2024-11-13
DiaMedica Therapeutics Inc. (DMAC)
-
DiaMedica Therapeutics Inc. Q2 FY2024 Earnings Call2024-08-07
DiaMedica Therapeutics Inc. (DMAC)
-
DiaMedica Therapeutics Inc. Q1 FY2024 Earnings Call2024-05-08
DiaMedica Therapeutics Inc. (DMAC)
-
DiaMedica Therapeutics Inc. Q4 FY2023 Earnings Call2024-03-19
DiaMedica Therapeutics Inc. (DMAC)